the French government seizes the High Council of public health

Following publication in The Lancet of a study alerting to the ineffectiveness and risks of certain treatments of Covid-19 including hydroxychloroquine, I asked the HCSP (High Council for Public Health) to analyze it and offer me within 48 hours a revision of the derogating prescription rules& nbsp; “, said French Minister of Health Olivier Véran on Twitter.” data-reactid = “20”> ” Following publication in The Lancet of a study alerting to the ineffectiveness and risks of certain treatments of Covid-19 including hydroxychloroquine, I asked the HCSP (High Council for Public Health) to analyze it and offer me within 48 hours a revision of the derogating prescription rules “, Says French Minister of Health Olivier Véran on Twitter.

The reaction was immediate. And for good reason: the study published in the prestigious medical journal deals again with the use of hydroxychloroquine for patients with Covid-19. It concerns 96,000 patients and shows that neither chloroquine nor hydroxychloroquine is effective against the coronavirus in hospitalized patients. On the contrary, these molecules even increase the risk of cardiac arrhythmia and the risk of death.

Before Olivier Véran asked for the prescription rules to be reviewed, France had already restricted the use of hydroxychloroquine, used only in hospitals and only for serious cases on the collegial decision of doctors.

Donald Trump announced that he takes it every day as a preventive measure, and Brazil’s Jair Bolsonaro recommended its use. “data-reactid =” 23 “> This molecule, derived from the antimalarial chloroquine, has known unprecedented fame since Professor Didier Raoult, Institut hospitalo-universitaire (IHU) in Marseille, relayed a small, little detailed Chinese study at the end of February, claiming that chloroquine phosphate was showing signs of effectiveness in patients with SARS-CoV2. the debates. The American president Donald Trump announced that he takes it every day preventively, and Brazil’s Jair Bolsonaro recommended its use.

It is not the first time that a study has contradicted Professor Raoult. Two other studies, one Chinese and the other French, published last week, have found that hydroxychloroquine does not reduce the risk of admission to intensive care or death in patients hospitalized with pneumonia due to Covid- 19.